Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma
Eric Bateman
View PDFchevron_right
Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*
H. Kankaanranta, Klaus Tamminen, Rudolf Huber
Current Medical Research and Opinion, 2008
View PDFchevron_right
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma:an efficacy and cost-effectiveness study
Olof Selroos
Current Medical Research and Opinion, 2006
View PDFchevron_right
Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy
Piotr Kuna
Allergy, 2007
View PDFchevron_right
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
Sarowar Golam
Allergy, Asthma & Clinical Immunology
View PDFchevron_right
A budget impact analysis of budesonide/formoterol in patients with mild asthma in Egypt
Gihan Elsisi
Journal of Medical Economics, 2019
View PDFchevron_right
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia
Chin Fen Neoh
Drugs & Therapy Perspectives, 2021
View PDFchevron_right
A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β2-agonists for asthma maintenance treatment in Germany
S. Cure
International Journal of Clinical Practice, 2008
View PDFchevron_right
Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 μ g twice daily and budesonide 800 μ g twice daily in the treatment of adults and adolescents with asthma
Afisi Ismaila
Respiratory Medicine, 2000
View PDFchevron_right
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial
Maria Pia Foschino
The Lancet Respiratory Medicine, 2014
View PDFchevron_right
Cost Effectiveness of Fluticasone and Budesonide in Patients with Moderate Asthma
Timm Volmer
Clinical Drug Investigation, 1998
View PDFchevron_right
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial
Stella Moon
The Lancet, 2019
View PDFchevron_right
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma
christina keen
The New England journal of medicine, 2018
View PDFchevron_right
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children
Kayleigh Kew
Reviews, 1996
View PDFchevron_right
A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management
G. Vandenhoven
International Journal of Clinical Practice, 2009
View PDFchevron_right
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps
Eric Bateman
Respiratory Research, 2011
View PDFchevron_right
Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma
Robert Rodriguez
American Journal of Respiratory and Critical Care Medicine, 2001
View PDFchevron_right
Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study
Tzu-Chin Wu, Pintip Ngamjanyaporn
BMC Pulmonary Medicine, 2013
View PDFchevron_right
Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma
christina keen
The New England journal of medicine, 2018
View PDFchevron_right
Cost–utility of inhaled corticosteroids in patients with moderate-to-severe asthma
Maria Cavallo
Expert Review of Pharmacoeconomics & Outcomes Research, 2004
View PDFchevron_right
Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study
Olof Selroos
Respiratory Medicine, 2012
View PDFchevron_right
Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial
Matire Harwood
The Lancet Respiratory Medicine, 2013
View PDFchevron_right
Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma
Piotr Kuna
Respiratory Medicine, 2006
View PDFchevron_right
Treatment Comparison of Budesonide/Formoterol with Salmeterol/Fluticasone Propionate in Adults Aged ≥16 Years with Asthma
Piotr Kuna
Clinical Drug Investigation, 2010
View PDFchevron_right
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study
Carin Jorup
Lancet, 2006
View PDFchevron_right
Fixed or Adjustable Maintenance-Dose Budesonide/Formoterol Compared with Fixed Maintenance-Dose Salmeterol/Fluticasone Propionate in Asthma Patients Aged ≥16 Years: Post Hoc Analysis of a Randomized, Double-Blind/Open-Label Extension, Parallel-Group Study
Rene Aalbers
Clinical Drug Investigation, 2010
View PDFchevron_right
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations
Ahmed Manjra
International Journal of Clinical Practice, 2007
View PDFchevron_right
Effect of a single day of increased as-needed budesonide–formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study
christina keen
The Lancet Respiratory Medicine, 2021
View PDFchevron_right
Efficacy and safety of high-dose budesonide/formoterol (SymbicortR) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma
Denis Caillaud
Respirology, 2006
View PDFchevron_right
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials
christina keen
Trials, 2017
View PDFchevron_right
Evaluation of the efficacy and safety of a fixed-dose, single-capsule budesonide-formoterol combination in uncontrolled asthma: a randomized, double-blind, multicenter, controlled clinical trial* Avaliação da eficácia e segurança da associação de budesonida e formoterol em dose fixa e cápsula úni...
Emílio Pizzichini
2012
View PDFchevron_right
Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide Alone
Ricardo Ramirez
The New England journal of medicine, 2016
View PDFchevron_right
Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1-year follow-up
T. McLaughlin
Respiratory Medicine, 2001
View PDFchevron_right
Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol
Amélie Forget
Respiratory Medicine, 2009
View PDFchevron_right